skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines Modified vaccinia ankara – bavarian nordic live virusQuestion & answer

Modified vaccinia ankara – bavarian nordic live virus · Medicine question

Can it be used after mpox exposure?

iatroX medicinesPublished 17 August 2026Reviewed 17 August 2026

The answer

Answer

Yes. UK public-health teams may offer it to eligible close contacts after assessing the nature and timing of exposure.

Sources for this answer

NHSNHS · NHS medicine guidance
UK Government

UK Government · Reputable Web

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

Modified vaccinia ankara – bavarian nordic live virus

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the Modified vaccinia ankara – bavarian nordic live virus guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX

More questions about Modified vaccinia ankara – bavarian nordic live virus

Can it cause mpox?Who is offered it for mpox prevention?Does it give complete protection?Is it suitable for someone with eczema?Can someone with HIV receive it?Can children receive it?